Marijuana Business News

Synonyms: 
stocks
business
Thu
17
Jan

Why marijuana ETF is on a high in 2019

After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback at the start of this year on the renewed appeal for riskier assets.

Thu
17
Jan

WeedMD moving with evolving cannabis industry, says Eight Capital, rating shares a Buy

Recent initiatives have shown that cannabis group WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF) is keeping up with changes as the marijuana industry evolves.

That's the view of broker Eight Capital, which rates the shares a Buy and has a target of $4.50, compared with the current price of $1.63. On Tuesday, WeedMD said it had become the first licensed producer in the world to include a cannabis strain authenticity and tracking platform into its sales program.

The firm now has 40 active cannabis strains from its genetics bank that hold the BLOCKStrain Certificate of Authenticity and can be cross-referenced as verifiable strains in BLOCKStrain's database. from genome to sale.

Thu
17
Jan

Ovation Science: CBD stock to watch

Ovation Science Inc.(CSE:OVAT) is a skincare research and development company that provides pharmaceutical-grade topical cannabis products for the medical and recreational global market. Through its patented Invisicare® technology, Ovation develops industry-leading transdermal and topical cannabis products using a licensing/royalty business model.

Thu
17
Jan

OrganiGram stock climbs as OGI breaks ground in the edibles space

OrganiGram stock is climbing today after OrganiGram Holdings (TSXV:OGI) announces its entrance into the cannabis edibles market.

Let’s dig in as this story develops!

OrganiGram Edibles

This morning, OrganiGram announced it has entered into a partnership with Canada’s Smartest Kitchen. Canada’s Smartest Kitchen is a leader in food product development.

Thu
17
Jan

MedMen Stock: Should you be looking at MedMen in 2019?

Investing in the cannabis market in 2019 could be one of the smartest financial decisions you can make. With MedMen stock on investors’ lips, is it worth considering MedMen Enterprises (CSE:MMEN) (OTCQB:MMNFF) for your portfolio this year?

MedMen Stock

Before we get into the nitty-gritty, it’s worth noting that 2019 is considered a transitionary year for cannabis. As such, it is an opportunistic time for investors if they choose the right stocks.

It’s transitionary for two reasons:

Thu
17
Jan

Is Aurora Cannabis Inc. (TSX:ACB) stock still oversold?

Marijuana stocks are enjoying a new rally and investors who stayed on the sidelines through the downturn at the end of 2018 are wondering which pot stocks might be the best buys right now.

Let’s take a look at Aurora Cannabis (TSX:ACB)(NYSE:ACB) to see if it deserves to be in your portfolio today.

Thu
17
Jan

Why are so many marijuana stocks making this key move?

After seeing struggles in 2018, marijuana stocks are back in the limelight. With new legalization efforts taking place and the evolution of the recreational cannabis market in Canada starting to become clearer, interest in top stocks in the industry has returned. So far in 2019, many cannabis stocks have posted big gains that in some cases have been enough to wipe out their losses last year.

Thu
17
Jan

3 marijuana stocks to watch now

Canopy Growth (NYSE:CGC) just announced that it plans to invest up to $150 million in New York state to target the emerging market for cannabis products derived from hemp, but it's not the only marijuana company that investors ought to be paying close attention to. 

Wed
16
Jan

Tilray, U.S. brand group partner on cannabis-infused consumer products

Licensed producer Tilray Inc. has teamed up with the U.S. company behind brands such as Juicy Couture, Aeropostale and Nine West to develop and sell co-branded consumer cannabis products globally, with items expected to hit U.S. and Canadian shelves within the next year.

The Nanaimo, B.C.-based company announced Tuesday the long-term revenue sharing agreement with Authentic Brands Group, to whom Tilray will initially pay US$100 million in cash and stock, or up to $250 million depending on certain milestones.

Tilray will receive up to 49 per cent of the net revenue from these products bearing names from ABG's portfolio of more than 50 brands, with a guaranteed minimum payment of up to US$10 million annually for 10 years.

Wed
16
Jan

Cannabis Canada Daily: Canopy's Linton says stock tumble 'kicks me in the butt'

Canopy CEO focuses on stabilizing stock volatility with institutional investors

Pages

Subscribe to RSS - Marijuana Business News